Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,251
datasets available to search
ShareScore release 0.9.0
Dataset results
3,251 results for “ovarian cancer”
A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer
ClinicalTrials.gov study NCT00937560. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT04352439. IPD Sharing: NO. Countries: 1. Publications: 3.
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
ClinicalTrials.gov study NCT02855944. IPD Sharing: Not stated. Countries: 12. Publications: 2.
Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer o
ClinicalTrials.gov study NCT02948426. IPD Sharing: YES. Countries: 1. Publications: 6.
A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)
ClinicalTrials.gov study NCT03657043. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.
ClinicalTrials.gov study NCT03106987. IPD Sharing: YES. Countries: 11. Publications: 1.
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
ClinicalTrials.gov study NCT01447706. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT03635489. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00267696. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00429793. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)
ClinicalTrials.gov study NCT01696994. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer
ClinicalTrials.gov study NCT02978222. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ova
ClinicalTrials.gov study NCT02580058. IPD Sharing: YES. Countries: 25. Publications: 3.
Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT02853318. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer
ClinicalTrials.gov study NCT00130520. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT03955471. IPD Sharing: NO. Countries: 1. Publications: 1.
Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT00526799. IPD Sharing: NO. Countries: 1. Publications: 1.
Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer
ClinicalTrials.gov study NCT00993655. IPD Sharing: NO. Countries: 4. Publications: 1.
Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00791778. IPD Sharing: Not stated. Countries: 14. Publications: 2.
Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)
ClinicalTrials.gov study NCT05092360. IPD Sharing: UNDECIDED. Countries: 14. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.